Table 1 Baseline characteristics of patients of the Prior Coronary Artery Bypass Graft Surgery and the Initial Transapical Transcatheter Aortic Valve Replacement Groups
|  | No CABG (N = 81) | CABG (N = 45) | P Value |
|---|---|---|---|
Age | 85.8 ± 6.1 | 82.5 ± 7.4 | 0.008 |
Male, (%) | 24 (29.6) | 28 (62.2) | <0.001 |
BMI | 25.58 ± 4.84 | 25.41 ± 4.70 | 0.853 |
STS Score | 8.99 ± 4.19 | 11.66 ± 5.47 | 0.003 |
NYHA III or IV | 56 (69.1) | 34 (75.6) | 0.539 |
Permanent PM | 9 (11.1) | 10 (22.2) | 0.120 |
ICD | 3 (3.7) | 8 (17.8) | 0.017 |
Atrial Fibrillation | 27 (33.3) | 20 (44.4) | 0.251 |
Previous MI | 16 (21.1) | 22 (55) | <0.001 |
Prior PCI | 41 (50.6) | 20 (44.4) | 0.578 |
Stroke | 8 (9.9) | 7 (15.6) | 0.395 |
Transient Ischemic Attack | 6 (7.4) | 6 (13.3) | 0.346 |
PAD | 25 (30.9) | 20 (44.4) | 0.174 |
Smoking History | 52 (64.2) | 30 (66.7) | 0.847 |
Hypertension | 69 (85.2) | 42 (93.3) | 0.253 |
Dyslipidemia | 59 (72.8) | 40 (88.9) | 0.042 |
Diabetes | 19 (23.5) | 20 (44.4) | 0.017 |
Oral Medications only | 9 (11.1) | 11 (24.4) | 0.073 |
Insulin only | 5 (6.2) | 5 (11.1) | 0.328 |
Immunocompromise Present | 12 (14.8) | 1 (2.2) | 0.031 |
Left Main Stenosis > 50% | 4 (4.9) | 19 (42.2) | <0.001 |
Proximal LAD > 70% stenosis | 13 (16.0) | 26 (57.8) | <0.001 |
Renal Dialysis | 3 (3.7) | 1 (2.2) | 1.0 |
Creatinine mg/dl | 1.28 ± 0.65 | 1.32 ± 0.48 | 0.686 |
Echocardiography | Â | Â | Â |
 Aortic Valve Area, cm2 | 0.67 ± 0.14 | 0.75 ± 0.20 | 0.025 |
 LVEF (%) | 54.3 ± 11.6 | 42.3 ± 15.3 | <0.001 |
 Aortic Valve Mean Gradient, mm Hg | 47.7 ± 12.5 | 44.1 ± 11.9 | 0.126 |
 Aortic Valve Peak Gradient, mm Hg | 82.5 ± 22.4 | 75.8 ± 18.6 | 0.091 |
 Aortic Valve Regurgitation Moderate/Severe | 1 (1.2) | 1 (2.2) | 1.0 |
 Mitral Valve Regurgitation Moderate/Severe | 13 (16.0) | 16 (35.6) | 0.016 |
 LVIDs, cm | 3.42 ± 1.21 | 4.05 ± 1.88 | 0.026 |
 LVIDd, cm | 4.96 ± 1.14 | 5.30 ± 1.91 | 0.212 |